A CHALLENGES AND CLINICAL IMPLICATION IN DAPSONEINDUCED HYPERSENSITIVITY SYNDROME IN BORDERLINE TUBERCULOID HANSEN’S DISEASE. CDF. 2024;53(03):3231-3236. doi:10.48047/5490j172